Evidence map›Paper›PMID 28509594›Full record

ArticleLeukemia & lymphoma2017

G-CSF improves safety when you start the day after autologous transplant in multiple myeloma.

Douglas W Sborov, Yu Kyoung Cho, Francesca Cottini, Erinn M Hade, Misty Lamprecht, Karen Tackett, Nidhi Sharma, Nita Williams, Junan Li, Steven Devine and 3 more

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Douglas W Sborova Division of Hematology, Department of Internal Medicine, College of Medicine, t he Ohio State University , Columbus , OH , USA.
Yu Kyoung Chob Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy , the Ohio State University , Columbus , OH , USA.
Francesca Cottinic Internal Medicine Residency Program, Department of Internal Medicine, College of Medicine , the Ohio State University , Columbus , OH , USA.
Erinn M Haded Center for Biostatistics, Department of Biomedical Informatics , the Ohio State University , Columbus , OH , USA.
Misty Lamprechte Ohio State University Wexner Medical Center, the Ohio State University , Columbus , OH , USA.
Karen Tackette Ohio State University Wexner Medical Center, the Ohio State University , Columbus , OH , USA.
Nidhi Sharmaa Division of Hematology, Department of Internal Medicine, College of Medicine, t he Ohio State University , Columbus , OH , USA.
Nita Williamsa Division of Hematology, Department of Internal Medicine, College of Medicine, t he Ohio State University , Columbus , OH , USA.
Junan Lib Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy , the Ohio State University , Columbus , OH , USA.
Steven Devinea Division of Hematology, Department of Internal Medicine, College of Medicine, t he Ohio State University , Columbus , OH , USA.
Ming Poib Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy , the Ohio State University , Columbus , OH , USA.
Mitch A Phelpsb Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy , the Ohio State University , Columbus , OH , USA.
Craig C Hofmeistera Division of Hematology, Department of Internal Medicine, College of Medicine, t he Ohio State University , Columbus , OH , USA.
The Ohio State University · USThe Ohio State University Wexner Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationAdultAgedAutograftsCombined Modality TherapyFemaleGranulocyte Colony-Stimulating FactorHumansMaleMiddle AgedMultiple MyelomaOdds RatioTreatment OutcomeGranulocyte Colony-Stimulating Factor

Identifiers

PMID28509594
PMCPMC6607907
OpenAlexW2615058979

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.